{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:25:13Z","timestamp":1793420713595,"version":"4.5.0"},"reference-count":235,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1038\/s41569-021-00632-2","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T11:07:24Z","timestamp":1637060844000},"page":"265-280","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":142,"title":["A fresh look at coronary microembolization"],"prefix":"10.1038","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3576-3772","authenticated-orcid":false,"given":"Petra","family":"Kleinbongard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7078-4160","authenticated-orcid":false,"given":"Gerd","family":"Heusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,16]]},"reference":[{"key":"632_CR1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/hrt.50.2.127","volume":"50","author":"E Falk","year":"1983","unstructured":"Falk, E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br. Heart J. 50, 127\u2013134 (1983).","journal-title":"Br. Heart J."},{"key":"632_CR2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/hrt.53.4.363","volume":"53","author":"MJ Davies","year":"1985","unstructured":"Davies, M. J. & Thomas, A. C. Plaque fissuring- the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br. Heart J. 53, 363\u2013373 (1985).","journal-title":"Br. Heart J."},{"key":"632_CR3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/01.CIR.71.4.699","volume":"71","author":"E Falk","year":"1985","unstructured":"Falk, E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and\/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 71, 699\u2013708 (1985).","journal-title":"Circulation"},{"key":"632_CR4","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1161\/01.CIR.62.5.936","volume":"62","author":"N El-Maraghi","year":"1980","unstructured":"El-Maraghi, N. & Genton, E. The relevance of platelet and fibrin thrombembolism of the coronary microcirculation, with special reference to sudden cardiac death. Circulation 62, 936\u2013944 (1980).","journal-title":"Circulation"},{"key":"632_CR5","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/01.CIR.73.3.418","volume":"73","author":"MJ Davies","year":"1986","unstructured":"Davies, M. J., Thomas, A. C., Knapman, P. A. & Hangartner, J. R. Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation 73, 418\u2013427 (1986).","journal-title":"Circulation"},{"key":"632_CR6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/hrt.59.2.196","volume":"59","author":"RJ Frink","year":"1988","unstructured":"Frink, R. J., Rooney, P. A., Trowbridge, J. O. & Rose, J. P. Coronary thrombosis and platelet\/fibrin microemboli in death associated with acute myocardial infarction. Br. Heart J. 59, 196\u2013200 (1988).","journal-title":"Br. Heart J."},{"key":"632_CR7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/01.CIR.65.2.248","volume":"65","author":"JD Folts","year":"1985","unstructured":"Folts, J. D., Gallagher, K. & Rowe, G. G. Blood flow reductions in stenosed canine coronary arteries: vasospasm or platelet aggregation? Circulation 65, 248\u2013255 (1985).","journal-title":"Circulation"},{"key":"632_CR8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1172\/JCI114138","volume":"84","author":"JF Eidt","year":"1989","unstructured":"Eidt, J. F. et al. Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury. J. Clin. Invest. 84, 18\u201327 (1989).","journal-title":"J. Clin. Invest."},{"key":"632_CR9","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/0735-1097(90)90652-6","volume":"15","author":"P Golino","year":"1990","unstructured":"Golino, P., Buja, M., Sheng-Kun, Y., McNatt, J. & Willerson, J. T. Failure of nitroglycerin and diltiazem to reduce platelet-mediated vasoconstriction in dogs with coronary artery stenosis and endothelial injury: further evidence for thromboxane A2 and serotonin as mediators of coronary artery vasoconstriction in vivo. J. Am. Coll. Cardiol. 15, 718\u2013726 (1990).","journal-title":"J. Am. Coll. Cardiol."},{"key":"632_CR10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0008-6363(99)00028-0","volume":"42","author":"JD Folts","year":"1999","unstructured":"Folts, J. D. Deleterious hemodynamic effects of thrombotic\/embolic materials on the distal myocardial vasculature. Cardiovasc. Res. 42, 6\u20137 (1999).","journal-title":"Cardiovasc. Res."},{"key":"632_CR11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0735-1097(00)00708-7","volume":"36","author":"R Erbel","year":"2000","unstructured":"Erbel, R. & Heusch, G. Brief review: coronary microembolization. J. Am. Coll. Cardiol. 36, 22\u201324 (2000).","journal-title":"J. Am. Coll. Cardiol."},{"key":"632_CR12","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/01.CIR.101.5.570","volume":"101","author":"EJ Topol","year":"2000","unstructured":"Topol, E. J. & Yadav, J. S. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 101, 570\u2013580 (2000).","journal-title":"Circulation"},{"key":"632_CR13","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.yjmcc.2011.09.017","volume":"52","author":"L Gregorini","year":"2012","unstructured":"Gregorini, L., Marco, J. & Heusch, G. Peri-interventional coronary vasomotion. J. Mol. Cell. Cardiol. 52, 883\u2013889 (2012).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"632_CR14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/CIRCRESAHA.118.311098","volume":"124","author":"P Libby","year":"2019","unstructured":"Libby, P., Pasterkamp, G., Crea, F. & Jang, I. K. Reassessing the mechanisms of acute coronary syndromes. Circ. Res. 124, 150\u2013160 (2019).","journal-title":"Circ. Res."},{"key":"632_CR15","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41569-021-00542-3","volume":"18","author":"AC Fahed","year":"2021","unstructured":"Fahed, A. C. & Jang, I. K. Plaque erosion and acute coronary syndromes: phenotype, molecular characteristics and future directions. Nat. Rev. Cardiol. 18, 724\u2013734 (2021).","journal-title":"Nat. Rev. Cardiol."},{"key":"632_CR16","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/jama.2021.0069","volume":"325","author":"D Kolte","year":"2021","unstructured":"Kolte, D., Libby, P. & Jang, I. K. New insights into plaque erosion as a mechanism of acute coronary syndromes. JAMA 325, 1043\u20131044 (2021).","journal-title":"JAMA"},{"key":"632_CR17","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","volume":"592","author":"P Libby","year":"2021","unstructured":"Libby, P. The changing landscape of atherosclerosis. Nature 592, 524\u2013533 (2021).","journal-title":"Nature"},{"key":"632_CR18","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1161\/CIRCULATIONAHA.117.030798","volume":"14","author":"E Puymirat","year":"2017","unstructured":"Puymirat, E. et al. Acute myocardial infarction: changes in patient characteristics, management, and 6-month outcomes over a period of 20 years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-elevation Myocardial Infarction) 1995 to 2015. Circulation 14, 1908\u20131919 (2017).","journal-title":"Circulation"},{"key":"632_CR19","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.jacc.2009.07.042","volume":"54","author":"RS Schwartz","year":"2009","unstructured":"Schwartz, R. S. et al. Microemboli and microvascular obstruction in acute coronary thrombosis and sudden coronary death relation to epicardial plaque histopathology. J. Am. Coll. Cardiol. 54, 2167\u20132173 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"632_CR20","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/eurheartj\/ehx786","volume":"39","author":"RA Partida","year":"2018","unstructured":"Partida, R. A., Libby, P., Crea, F. & Jang, I. K. Plaque erosion: a new in vivo diagnosis and a potential major shift in the management of patients with acute coronary syndromes. Eur. Heart J. 39, 2070\u20132076 (2018).","journal-title":"Eur. Heart J."},{"key":"632_CR21","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","volume":"42","author":"JP Collet","year":"2021","unstructured":"Collet, J. P. et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur. Heart J. 42, 1289\u20131367 (2021).","journal-title":"Eur. Heart J."},{"key":"632_CR22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00000441-192602010-00002","volume":"171","author":"WW Hamburger","year":"1926","unstructured":"Hamburger, W. W., Priest, W. S., Bettman, R. B. & Howard, H. C. Experimental coronary embolism. Am. J. Med. Sci. 171, 168\u2013185 (1926).","journal-title":"Am. J. Med. Sci."},{"key":"632_CR23","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1152\/ajplegacy.1952.170.3.536","volume":"170","author":"CM Agress","year":"1952","unstructured":"Agress, C. M. et al. Protracted shock in the closed-chest dog following coronary embolization with graded microspheres. Am. J. Physiol. 170, 536\u2013549 (1952).","journal-title":"Am. J. Physiol."},{"key":"632_CR24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/00000441-195611000-00007","volume":"232","author":"RJ Bing","year":"1956","unstructured":"Bing, R. J., Castellanos, A., Gradel, E., Lupton, C. & Siegel, A. Experimental myocardial infarction: circulatory biochemical and pathologic changes. Am. J. Med. Sci. 232, 533\u2013554 (1956).","journal-title":"Am. J. Med. Sci."},{"key":"632_CR25","first-page":"190","volume":"13","author":"E Marcus","year":"1958","unstructured":"Marcus, E. et al. The production of myocardial infarction. Chronic coronary insufficiency and chronic coronary heart disease in the dog. Acta Cardiol. 13, 190\u2013198 (1958).","journal-title":"Acta Cardiol."},{"key":"632_CR26","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/01.RES.10.5.739","volume":"10","author":"SV Guzman","year":"1962","unstructured":"Guzman, S. V., Swenson, E. & Jones, M. Intercoronary reflex. Demonstration by coronary angiography. Circ. Res. 10, 739\u2013745 (1962).","journal-title":"Circ. Res."},{"key":"632_CR27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0002-9149(62)90098-X","volume":"9","author":"JA Jacoby","year":"1962","unstructured":"Jacoby, J. A., Taylor, W. J., Smith, G. T., Gorlin, R. & Harken, D. E. A new therapeutic approach to acute coronary occlusion. Production of standardized coronary occlusion with microspheres. Am. J. Cardiol. 9, 60\u201373 (1962).","journal-title":"Am. J. Cardiol."},{"key":"632_CR28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1152\/ajplegacy.1966.210.1.169","volume":"210","author":"RM Herzberg","year":"1966","unstructured":"Herzberg, R. M., Rubio, R. & Berne, R. M. Coronary occlusion and embolization: effect on blood flow in adjacent arteries. Am. J. Physiol. 210, 169\u2013175 (1966).","journal-title":"Am. J. Physiol."},{"key":"632_CR29","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1172\/JCI106655","volume":"50","author":"RG Monroe","year":"1971","unstructured":"Monroe, R. G., LaFarge, C. G., Gamble, W. J., Kumar, A. E. & Manasek, F. J. Left ventricular performance and coronary flow after coronary embolization with plastic microspheres. J. Clin. Invest. 50, 1656\u20131665 (1971).","journal-title":"J. Clin. Invest."},{"key":"632_CR30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1053\/pcad.2001.26968","volume":"44","author":"G Heusch","year":"2001","unstructured":"Heusch, G., Schulz, R., Baumgart, D., Haude, M. & Erbel, R. Coronary microembolization. Prog. Cardiovasc. Dis. 44, 217\u2013230 (2001).","journal-title":"Prog. Cardiovasc. Dis."},{"key":"632_CR31","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1161\/CIRCULATIONAHA.109.888784","volume":"120","author":"G Heusch","year":"2009","unstructured":"Heusch, G. et al. Coronary microembolization: from bedside to bench and back to bedside. Circulation 120, 1822\u20131836 (2009).","journal-title":"Circulation"},{"key":"632_CR32","first-page":"H477","volume":"239","author":"JA Franciosa","year":"1980","unstructured":"Franciosa, J. A., Heckel, R., Limas, C. & Cohn, J. N. Progressive myocardial dysfunction associated with increased vascular resistance. Am. J. Physiol. 239, H477\u2013H482 (1980).","journal-title":"Am. J. Physiol."},{"key":"632_CR33","first-page":"H1379","volume":"29","author":"HN Sabbah","year":"1991","unstructured":"Sabbah, H. N. et al. A canine model of chronic heart failure produced by multiple sequential coronary microembolizations. Am. J. Physiol. 29, H1379\u2013H1384 (1991).","journal-title":"Am. J. Physiol."},{"key":"632_CR34","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/01.RES.54.1.74","volume":"54","author":"C Eng","year":"1984","unstructured":"Eng, C., Cho, S., Factor, S. M., Sonnenblick, E. H. & Kirk, E. S. Myocardial micronecrosis produced by microsphere embolization. Role of an alpha-adrenergic tonic influence on the coronary microcirculation. Circ. Res. 54, 74\u201382 (1984).","journal-title":"Circ. Res."},{"key":"632_CR35","first-page":"H509","volume":"250","author":"M Hori","year":"1986","unstructured":"Hori, M. et al. Role of adenosine in hyperemic response of coronary blood flow in microcirculation. Am. J. Physiol. 250, H509\u2013H518 (1986).","journal-title":"Am. J. Physiol."},{"key":"632_CR36","doi-asserted-by":"crossref","first-page":"H2587","DOI":"10.1152\/ajpheart.2000.279.6.H2587","volume":"279","author":"H D\u00f6rge","year":"2000","unstructured":"D\u00f6rge, H. et al. Perfusion-contraction mismatch with coronary microvascular obstruction: role of inflammation. Am. J. Physiol. Heart Circ. Physiol. 279, H2587\u2013H2592 (2000).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"632_CR37","first-page":"H533","volume":"277","author":"F Grund","year":"1999","unstructured":"Grund, F., Sommerschild, H. T., Lyberg, T., Kirkeboen, K. & Ilebekk, A. Microembolization in pigs: effects on coronary blood flow and myocardial ischemic tolerance. Am. J. Physiol. 277, H533\u2013H542 (1999).","journal-title":"Am. J. Physiol."},{"key":"632_CR38","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1161\/01.RES.0000014451.75415.36","volume":"90","author":"M Thielmann","year":"2002","unstructured":"Thielmann, M. et al. Myocardial dysfunction with coronary microembolization: signal transduction through a sequence of nitric oxide, tumor necrosis factor-a and sphingosine. Circ. Res. 90, 807\u2013813 (2002).","journal-title":"Circ. Res."},{"key":"632_CR39","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1161\/01.CIR.0000143631.15077.0F","volume":"110","author":"NM Malyar","year":"2004","unstructured":"Malyar, N. M., Lerman, L. O., G\u00f6ssl, M., Beighley, P. E. & Ritman, E. L. Relation of nonperfused myocardial volume and surface area to left ventricular performance in coronary microembolization. Circulation 110, 1946\u20131952 (2004).","journal-title":"Circulation"},{"key":"632_CR40","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1148\/radiol.2503081000","volume":"250","author":"M Carlsson","year":"2009","unstructured":"Carlsson, M., Wilson, M., Martin, A. J. & Saeed, M. Myocardial microinfarction after coronary microembolization in swine: MR imaging characterization. Radiology 250, 703\u2013713 (2009).","journal-title":"Radiology"},{"key":"632_CR41","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1053\/euhj.2001.2963","volume":"23","author":"GD Dispersyn","year":"2002","unstructured":"Dispersyn, G. D. et al. Dissociation of cardiomyocyte apoptosis and dedifferentiation in infarct border zones. Eur. Heart J. 23, 849\u2013857 (2002).","journal-title":"Eur. Heart J."},{"key":"632_CR42","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.4103\/0366-6999.195469","volume":"129","author":"YY Cao","year":"2016","unstructured":"Cao, Y. Y. et al. Establishment of a novel mouse model of coronary microembolization. Chin. Med. J. 129, 2951\u20132957 (2016).","journal-title":"Chin. Med. J."},{"key":"632_CR43","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11010-010-0482-x","volume":"342","author":"L Li","year":"2010","unstructured":"Li, L., Zhao, X., Lu, Y., Huang, W. & Wen, W. Altered expression of pro- and anti-inflammatory cytokines is associated with reduced cardiac function in rats following coronary microembolization. Mol. Cell. Biochem. 342, 183\u2013190 (2010).","journal-title":"Mol. Cell. Biochem."},{"key":"632_CR44","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00395-009-0067-6","volume":"105","author":"S Li","year":"2009","unstructured":"Li, S. et al. Blockade of NF-kappaB by pyrrolidine dithiocarbamate attenuates myocardial inflammatory response and ventricular dysfunction following coronary microembolization induced by homologous microthrombi in rats. Basic Res. Cardiol. 105, 139\u2013150 (2009).","journal-title":"Basic Res. Cardiol."},{"key":"632_CR45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fcvm.2019.00157","volume":"6","author":"O Bikou","year":"2019","unstructured":"Bikou, O. et al. A novel large animal model of thrombogenic coronary microembolization. Front. Cardiovasc. Med. 6, 157 (2019).","journal-title":"Front. Cardiovasc. Med."},{"key":"632_CR46","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF01906748","volume":"80","author":"KP Gallagher","year":"1985","unstructured":"Gallagher, K. P., Osakada, G., Kemper, W. S. & Ross, J. Jr Cyclical coronary flow reductions in conscious dogs equipped with ameroid constrictors to produce severe coronary narrowing. Basic Res. Cardiol. 80, 100\u2013106 (1985).","journal-title":"Basic Res. Cardiol."},{"key":"632_CR47","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0008-6363(00)00110-3","volume":"47","author":"JA Barrab\u00e9s","year":"2000","unstructured":"Barrab\u00e9s, J. A. et al. Dynamic intracoronary thrombosis does not cause significant downstream platelet embolization. Cardiovasc. Res. 47, 265\u2013273 (2000).","journal-title":"Cardiovasc. Res."},{"key":"632_CR48","doi-asserted-by":"crossref","first-page":"H611","DOI":"10.1152\/ajpheart.00797.2001","volume":"282","author":"A Skyschally","year":"2002","unstructured":"Skyschally, A., Schulz, R., Erbel, R. & Heusch, G. Reduced coronary and inotropic reserves with coronary microembolization. Am. J. Physiol. Heart Circ. Physiol. 282, H611\u2013H614 (2002).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"632_CR49","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1152\/ajplegacy.1951.166.3.603","volume":"166","author":"CM Agress","year":"1951","unstructured":"Agress, C. M., Rosenburg, M. J., Binder, M. J., Schneiderman, A. & Clark, W. G. Blood volume changes in protracted shock resulting from experimental myocardial infarction. Am. J. Physiol. 166, 603\u2013609 (1951).","journal-title":"Am. J. Physiol."},{"key":"632_CR50","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1161\/CIRCRESAHA.113.301446","volume":"112","author":"G Heusch","year":"2013","unstructured":"Heusch, G. The regional myocardial flow-function relationship: a framework for an understanding of acute ischemia, hibernation, stunning and coronary microembolization. Circ. Res. 112, 1535\u20131537 (2013).","journal-title":"Circ. Res."},{"key":"632_CR51","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s003950050069","volume":"93","author":"M Arras","year":"1998","unstructured":"Arras, M. et al. Tumor necrosis factor-\u03b1 is expressed by monocytes\/macrophages following cardiac microembolization and is antagonized by cyclosporine. Basic Res. Cardiol. 93, 97\u2013107 (1998).","journal-title":"Basic Res. Cardiol."},{"key":"632_CR52","first-page":"161","volume":"18","author":"Q Su","year":"2013","unstructured":"Su, Q. et al. Effect of metoprolol on myocardial apoptosis and caspase-9 activation after coronary microembolization in rats. Exp. Clin. Cardiol. 18, 161\u2013165 (2013).","journal-title":"Exp. Clin. Cardiol."},{"key":"632_CR53","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000369246","volume":"130","author":"YC Liu","year":"2015","unstructured":"Liu, Y. C., Li, L., Su, Q., Liu, T. & Tang, Z. L. Trimetazidine pretreatment inhibits myocardial apoptosis and improves cardiac function in a swine model of coronary microembolization. Cardiology 130, 130\u2013136 (2015).","journal-title":"Cardiology"},{"key":"632_CR54","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00210-019-01661-y","volume":"392","author":"Q Mao","year":"2019","unstructured":"Mao, Q., Liang, X., Wu, Y. & Lu, Y. Nobiletin protects against myocardial injury and myocardial apoptosis following coronary microembolization via activating PI3K\/Akt pathway in rats. Naunyn Schmiedebergs Arch. Pharmacol. 392, 1121\u20131130 (2019).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"632_CR55","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/1074248419845916","volume":"24","author":"Q Mao","year":"2019","unstructured":"Mao, Q., Liang, X., Wu, Y. & Lu, Y. Resveratrol attenuates cardiomyocyte apoptosis in rats induced by coronary microembolization through SIRT1-mediated deacetylation of p53. J. Cardiovasc. Pharmacol. Ther. 24, 551\u2013558 (2019).","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"632_CR56","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.714","volume":"9","author":"Y Yuan","year":"2021","unstructured":"Yuan, Y., Li, B., Peng, W. & Xu, Z. Protective effect of glycyrrhizin on coronary microembolization-induced myocardial dysfunction in rats. Pharmacol. Res. Perspect. 9, e00714 (2021).","journal-title":"Pharmacol. Res. Perspect."},{"key":"632_CR57","doi-asserted-by":"crossref","first-page":"693257","DOI":"10.3389\/fcvm.2021.693257","volume":"8","author":"Z-Q Chen","year":"2021","unstructured":"Chen, Z.-Q. et al. miR-200a-3p attenuates coronary microembolization-induced myocardial injury in rats by inhibiting TXNIP\/NLRP3-mediated cardiomyocyte pyroptosis. Front. Cardiovasc. Med. 8, 693257 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"632_CR58","doi-asserted-by":"crossref","first-page":"637598","DOI":"10.3389\/fimmu.2021.637598","volume":"12","author":"Y Zhou","year":"2021","unstructured":"Zhou, Y. et al. Overexpression of lncRNA TUG1 alleviates NLRP3 inflammasome-mediated cardiomyocyte pyroptosis through targeting the miR-186-5p\/XIAP axis in coronary microembolization-induced myocardial damage. Front. Immunol. 12, 637598 (2021).","journal-title":"Front. Immunol."},{"key":"632_CR59","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/01.CIR.84.2.828","volume":"84","author":"M Hori","year":"1991","unstructured":"Hori, M. et al. Role of oxygen-derived free radicals in myocardial edema and ischemia in coronary microvascular embolization. Circulation 84, 828\u2013840 (1991).","journal-title":"Circulation"},{"key":"632_CR60","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/mrm.23149","volume":"67","author":"M Saeed","year":"2012","unstructured":"Saeed, M. et al. Evaluation of the acute effects of distal coronary microembolization using multidetector computed tomography and magnetic resonance imaging. Magn. Reson. Med. 67, 1747\u20131757 (2012).","journal-title":"Magn. Reson. Med."},{"key":"632_CR61","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1006\/jmcc.2001.1489","volume":"34","author":"H D\u00f6rge","year":"2002","unstructured":"D\u00f6rge, H. et al. Coronary microembolization: the role of TNFa in contractile dysfunction. J. Mol. Cell. Cardiol. 34, 51\u201362 (2002).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"632_CR62","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000321713","volume":"117","author":"L Li","year":"2010","unstructured":"Li, L., Li, D. H., Qu, N., Wen, W. M. & Huang, W. Q. Signaling pathway in coronary microembolization-induced rat myocardial inflammation and injury. Cardiology 117, 207\u2013215 (2010).","journal-title":"Cardiology"},{"key":"632_CR63","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0008-6363(96)88599-3","volume":"29","author":"A Kluge","year":"1995","unstructured":"Kluge, A. et al. Insulin-like growth factor I is involved in inflammation linked angiogenic processes after microembolisation in porcine heart. Cardiovasc. Res. 29, 404\u2013415 (1995).","journal-title":"Cardiovasc. Res."},{"key":"632_CR64","first-page":"H1103","volume":"258","author":"WM Chilian","year":"1990","unstructured":"Chilian, W. M. et al. Microvascular occlusions promote coronary collateral growth. Am. J. Physiol. 258, H1103\u2013H1111 (1990).","journal-title":"Am. J. Physiol."},{"key":"632_CR65","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1148\/radiol.2493080457","volume":"249","author":"K Nassenstein","year":"2008","unstructured":"Nassenstein, K. et al. How much myocardial damage is necessary to enable detection of focal late gadolinium enhancement at cardiac MR imaging? Radiology 249, 829\u2013835 (2008).","journal-title":"Radiology"},{"key":"632_CR66","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jcmg.2008.10.011","volume":"2","author":"F Breuckmann","year":"2009","unstructured":"Breuckmann, F. et al. Systematic analysis of functional and structural changes after coronary microembolization: a cardiac magnetic resonance imaging study. JACC Imaging 2, 121\u2013130 (2009).","journal-title":"JACC Imaging"},{"key":"632_CR67","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/14017431.2011.568629","volume":"45","author":"M Carlsson","year":"2011","unstructured":"Carlsson, M., Jablonowski, R., Martin, A. J., Ursell, P. C. & Saeed, M. Coronary microembolization causes long-term detrimental effects on regional left ventricular function. Scand. Cardiovasc. J. 45, 205\u2013214 (2011).","journal-title":"Scand. Cardiovasc. J."},{"key":"632_CR68","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1161\/01.CIR.0000127961.66744.F4","volume":"109","author":"A Skyschally","year":"2004","unstructured":"Skyschally, A. et al. Glucocorticoid treatment prevents progressive myocardial dysfunction resulting from experimental coronary microembolization. Circulation 109, 2337\u20132342 (2004).","journal-title":"Circulation"},{"key":"632_CR69","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/eurheartj\/ehi751","volume":"27","author":"M Canton","year":"2006","unstructured":"Canton, M. et al. Oxidative modification of tropomyosin and myocardial dysfunction following coronary microembolization. Eur. Heart J. 27, 875\u2013881 (2006).","journal-title":"Eur. Heart J."},{"key":"632_CR70","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00395-008-0732-1","volume":"103","author":"A Skyschally","year":"2008","unstructured":"Skyschally, A. et al. Reduced calcium responsiveness characterizes contractile dysfunction following coronary microembolization. Basic Res. Cardiol. 103, 552\u2013559 (2008).","journal-title":"Basic Res. Cardiol."},{"key":"632_CR71","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2147\/DDDT.S293382","volume":"15","author":"ZQ Chen","year":"2021","unstructured":"Chen, Z. Q. et al. Breviscapine pretreatment inhibits myocardial inflammation and apoptosis in rats after coronary microembolization by activating the PI3K\/Akt\/GSK-3\u03b2 signaling pathway. Drug Des. Devel. Ther. 15, 843\u2013855 (2021).","journal-title":"Drug Des. Devel. Ther."},{"key":"632_CR72","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4196\/kjpp.2021.25.2.147","volume":"25","author":"ZQ Chen","year":"2021","unstructured":"Chen, Z. Q. et al. Puerarin pretreatment attenuates cardiomyocyte apoptosis induced by coronary microembolization in rats by activating the PI3K\/Akt\/GSK-3\u03b2 signaling pathway. Korean J. Physiol. Pharmacol. 25, 147\u2013157 (2021).","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"632_CR73","volume":"9","author":"J Zheng","year":"2021","unstructured":"Zheng, J. et al. Nicorandil inhibits cardiomyocyte apoptosis and improves cardiac function by suppressing the HtrA2\/XIAP\/PARP signaling after coronary microembolization in rats. Pharmacol. Res. Perspect. 9, e00699 (2021).","journal-title":"Pharmacol. Res. Perspect."},{"key":"632_CR74","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","volume":"17","author":"G Heusch","year":"2020","unstructured":"Heusch, G. Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat. Rev. Cardiol. 17, 773\u2013789 (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"632_CR75","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0895-7061(00)00266-1","volume":"13","author":"A Schmermund","year":"2000","unstructured":"Schmermund, A. et al. Effects of acute and chronic angiotensin receptor blockade on myocardial vascular blood volume and perfusion in a pig model of coronary microembolization. Am. J. Hypertens. 13, 827\u2013837 (2000).","journal-title":"Am. J. Hypertens."},{"key":"632_CR76","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1161\/01.RES.0000255031.15793.86","volume":"100","author":"A Skyschally","year":"2007","unstructured":"Skyschally, A. et al. Bidirectional role of tumor necrosis factor-\u03b1 in coronary microembolization: progressive contractile dysfunction versus delayed protection against infarction. Circ. Res. 100, 140\u2013146 (2007).","journal-title":"Circ. Res."},{"key":"632_CR77","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cardiores.2004.04.003","volume":"63","author":"A Skyschally","year":"2004","unstructured":"Skyschally, A. et al. Coronary microembolization does not induce acute preconditioning against infarction in pigs \u2013 the role of adenosine. Cardiovasc. Res. 63, 313\u2013322 (2004).","journal-title":"Cardiovasc. Res."},{"key":"632_CR78","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.yjmcc.2005.04.003","volume":"39","author":"A Skyschally","year":"2005","unstructured":"Skyschally, A. et al. Preinfarction angina: no interference of coronary microembolization with acute ischemic preconditioning. J. Mol. Cell. Cardiol. 39, 355\u2013361 (2005).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"632_CR79","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehs434","volume":"34","author":"A Skyschally","year":"2013","unstructured":"Skyschally, A., Walter, B. & Heusch, G. Coronary microembolization during early reperfusion\u2013infarct extension, but protection by ischemic postconditioning. Eur. Heart J. 34, 3314\u20133321 (2013).","journal-title":"Eur. Heart J."},{"key":"632_CR80","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/01.RES.19.1.57","volume":"19","author":"A Krug","year":"1966","unstructured":"Krug, A., du Mesnil de Rochemont, W. & Korb, G. Blood supply of the myocardium after temporary coronary occlusion. Circ. Res. 19, 57\u201362 (1966).","journal-title":"Circ. Res."},{"key":"632_CR81","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1172\/JCI107898","volume":"54","author":"RA Kloner","year":"1974","unstructured":"Kloner, R. A., Ganote, C. E. & Jennings, R. B. The \u201cno-reflow\u201d phenomenon after temporary coronary occlusion in the dog. J. Clin. Invest. 54, 1496\u20131508 (1974).","journal-title":"J. Clin. Invest."},{"key":"632_CR82","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/CIRCRESAHA.116.308640","volume":"118","author":"G Heusch","year":"2016","unstructured":"Heusch, G. The coronary circulation as a target of cardioprotection. Circ. Res. 118, 1643\u20131658 (2016).","journal-title":"Circ. Res."},{"key":"632_CR83","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00395-019-0756-8","volume":"114","author":"G Heusch","year":"2019","unstructured":"Heusch, G. Coronary microvascular obstruction: the new frontier in cardioprotection. Basic Res. Cardiol. 114, 45 (2019).","journal-title":"Basic Res. Cardiol."},{"key":"632_CR84","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0008-6363(99)00140-6","volume":"43","author":"S Kogaki","year":"1999","unstructured":"Kogaki, S. et al. Selectin on activated platelets enhances neutrophil endothelial adherence in myocardial reperfusion injury. Cardiovasc. Res. 43, 968\u2013973 (1999).","journal-title":"Cardiovasc. Res."},{"key":"632_CR85","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jacc.2004.09.068","volume":"45","author":"JA Barrabes","year":"2005","unstructured":"Barrabes, J. A. et al. Antagonism of selectin function attenuates microvascular platelet deposition and platelet-mediated myocardial injury after transient ischemia. J. Am. Coll. Cardiol. 45, 293\u2013299 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"632_CR86","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1365-2362.2007.01883.x","volume":"37","author":"JA Barrabes","year":"2007","unstructured":"Barrabes, J. A. et al. Platelet deposition in remote cardiac regions after coronary occlusion. Eur. J. Clin. Invest. 37, 939\u2013946 (2007).","journal-title":"Eur. J. Clin. Invest."},{"key":"632_CR87","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/187152910793743797","volume":"10","author":"JA Barrabes","year":"2010","unstructured":"Barrabes, J. A. et al. Microvascular thrombosis: an exciting but elusive therapeutic target in reperfused acute myocardial infarction. Cardiovasc. Hematol. Disord. Drug Targets 10, 273\u2013283 (2010).","journal-title":"Cardiovasc. Hematol. Disord. Drug Targets"},{"key":"632_CR88","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.carpath.2011.07.008","volume":"21","author":"RB Driesen","year":"2012","unstructured":"Driesen, R. B. et al. Histological correlate of a cardiac magnetic resonance imaged microvascular obstruction in a porcine model of ischemia-reperfusion. Cardiovasc. Pathol. 21, 129\u2013131 (2012).","journal-title":"Cardiovasc. Pathol."},{"key":"632_CR89","first-page":"2520","volume":"9","author":"H Zhu","year":"2017","unstructured":"Zhu, H. et al. Prostaglandin E1 protects coronary microvascular function via the glycogen synthase kinase 3beta-mitochondrial permeability transition pore pathway in rat hearts subjected to sodium laurate-induced coronary microembolization. Am. J. Transl. Res. 9, 2520\u20132534 (2017).","journal-title":"Am. J. Transl. Res."},{"key":"632_CR90","first-page":"141","volume":"148","author":"VG Sharov","year":"1997","unstructured":"Sharov, V. G. et al. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am. J. Pathol. 148, 141\u2013149 (1997).","journal-title":"Am. J. Pathol."},{"key":"632_CR91","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1161\/01.CIR.89.6.2852","volume":"89","author":"HN Sabbah","year":"1994","unstructured":"Sabbah, H. N. et al. Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction. Circulation 89, 2852\u20132859 (1994).","journal-title":"Circulation"},{"key":"632_CR92","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cardiores.2004.06.007","volume":"64","author":"K-L He","year":"2004","unstructured":"He, K.-L. et al. Mechanisms of heart failure with well preserved ejection fraction in dogs following limited coronary microembolization. Cardiovasc. Res. 64, 72\u201383 (2004).","journal-title":"Cardiovasc. Res."},{"key":"632_CR93","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1177\/000331979704800803","volume":"48","author":"H Ikram","year":"1997","unstructured":"Ikram, H. et al. An ovine model of acute myocardial infarction and chronic left ventricular dysfunction. Angiology 48, 679\u2013688 (1997).","journal-title":"Angiology"},{"key":"632_CR94","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/cvr\/cvr106","volume":"91","author":"I George","year":"2011","unstructured":"George, I., Sabbah, H. N., Xu, K., Wang, N. & Wang, J. \u03b2-Adrenergic receptor blockade reduces endoplasmic reticulum stress and normalizes calcium handling in a coronary embolization model of heart failure in canines. Cardiovasc. Res. 91, 447\u2013455 (2011).","journal-title":"Cardiovasc. Res."},{"key":"632_CR95","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/S0735-1097(00)00913-X","volume":"36","author":"HN Sabbah","year":"2000","unstructured":"Sabbah, H. N. et al. Chronic therapy with metoprolol attenuates cardiomyocyte apoptosis in dogs with heart failure. J. Am. Coll. Cardiol. 36, 1698\u20131705 (2000).","journal-title":"J. Am. Coll. Cardiol."},{"key":"632_CR96","doi-asserted-by":"crossref","first-page":"6940195","DOI":"10.1155\/2016\/6940195","volume":"2016","author":"G Suzuki","year":"2016","unstructured":"Suzuki, G., Young, R. F., Leiker, M. M. & Suzuki, T. Heart-derived stem cells in miniature swine with coronary microembolization: Novel ischemic cardiomyopathy model to assess the efficacy of cell-based therapy. Stem Cell Int. 2016, 6940195 (2016).","journal-title":"Stem Cell Int."},{"key":"632_CR97","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/oxfordjournals.eurheartj.a061073","volume":"16","author":"IH Leach","year":"1995","unstructured":"Leach, I. H., Blundell, J. W., Rowley, J. M. & Turner, D. R. Acute ischaemic lesions in death due to ischaemic heart disease. An autopsy study of 333 cases of out-of-hospital death. Eur. Heart J. 16, 1181\u20131185 (1995).","journal-title":"Eur. Heart J."},{"key":"632_CR98","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/clinchem\/hvaa228","volume":"67","author":"PM Haller","year":"2021","unstructured":"Haller, P. M., Beer, B. N., Tonkin, A. M., Blankenberg, S. & Neumann, J. T. Role of cardiac biomarkers in epidemiology and risk outcomes. Clin. Chem. 67, 96\u2013106 (2021).","journal-title":"Clin. Chem."},{"key":"632_CR99","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1093\/cvr\/cvx183","volume":"113","author":"KC Park","year":"2017","unstructured":"Park, K. C., Gaze, D. C., Collinson, P. O. & Marber, M. S. Cardiac troponins: from myocardial infarction to chronic disease. Cardiovasc. Res. 113, 1708\u20131718 (2017).","journal-title":"Cardiovasc. Res."},{"key":"632_CR100","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jcin.2017.08.057","volume":"11","author":"CE Raphael","year":"2018","unstructured":"Raphael, C. E. et al. Coronary embolus: An underappreciated cause of acute coronary syndromes. JACC Cardiovasc. Interv. 11, 172\u2013180 (2018).","journal-title":"JACC Cardiovasc. Interv."},{"key":"632_CR101","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/0735-1097(93)90531-5","volume":"22","author":"RS Saber","year":"1993","unstructured":"Saber, R. S. et al. Coronary embolization after balloon angioplasty or thrombolytic therapy: an autopsy study of 32 cases. J. Am. Coll. Cardiol. 22, 1283\u20131288 (1993).","journal-title":"J. Am. Coll. Cardiol."},{"key":"632_CR102","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1093\/eurheartj\/ehx414","volume":"38","author":"S de Waha","year":"2017","unstructured":"de Waha, S. et al. Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials. Eur. Heart J. 38, 3502\u20133510 (2017).","journal-title":"Eur. Heart J."},{"key":"632_CR103","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005841","volume":"10","author":"A Durante","year":"2017","unstructured":"Durante, A. et al. Identification of high-risk patients after ST-segment-elevation myocardial infarction: Comparison between angiographic and magnetic resonance parameters. Circ. Cardiovasc. Imaging 10, e005841 (2017).","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"632_CR104","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.acvd.2020.05.024","volume":"113","author":"T Pezel","year":"2020","unstructured":"Pezel, T. et al. Predictive value of early cardiac magnetic resonance imaging functional and geometric indexes for adverse left ventricular remodelling in patients with anterior ST-segment elevation myocardial infarction: a report from the CIRCUS study. Arch. Cardiovasc. Dis. 113, 710\u2013720 (2020).","journal-title":"Arch. Cardiovasc. Dis."},{"key":"632_CR105","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/CIRCRESAHA.119.315344","volume":"125","author":"G Niccoli","year":"2019","unstructured":"Niccoli, G. et al. Optimized treatment of ST-elevation myocardial infarction: the unmet need to target coronary microvascular obstruction as primary treatment goal to further improve prognosis. Circ. Res. 125, 245\u2013258 (2019).","journal-title":"Circ. Res."},{"key":"632_CR106","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez, B. et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 39, 119\u2013177 (2018).","journal-title":"Eur. Heart J."},{"key":"632_CR107","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehi455","volume":"26","author":"J Herrmann","year":"2005","unstructured":"Herrmann, J. Peri-procedural myocardial injury: 2005 update. Eur. Heart J. 26, 2493\u20132519 (2005).","journal-title":"Eur. Heart J."},{"key":"632_CR108","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/eurheartj\/ehq393","volume":"32","author":"G Ganesha Babu","year":"2011","unstructured":"Ganesha Babu, G., Malcolm, W. J., Yellon, D. M. & Hausenloy, D. J. Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection. Eur. Heart J. 32, 23\u201331 (2011).","journal-title":"Eur. Heart J."},{"key":"632_CR109","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","volume":"138","author":"K Thygesen","year":"2018","unstructured":"Thygesen, K. et al. Fourth universal definition of myocardial infarction (2018). Circulation 138, e618\u2013e651 (2018).","journal-title":"Circulation"},{"key":"632_CR110","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1093\/eurheartj\/ehab271","volume":"42","author":"H Bulluck","year":"2021","unstructured":"Bulluck, H. et al. Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a consensus document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J. 42, 2630\u20132642 (2021).","journal-title":"Eur. Heart J."},{"key":"632_CR111","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1475-2840-12-12","volume":"12","author":"T Baars","year":"2013","unstructured":"Baars, T. et al. Coronary aspirate TNFalpha reflects saphenous vein bypass graft restenosis risk in diabetic patients. Cardiovasc. Diabetol. 12, 12 (2013).","journal-title":"Cardiovasc. Diabetol."},{"key":"632_CR112","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00395-012-0303-3","volume":"107","author":"T Baars","year":"2012","unstructured":"Baars, T. et al. Saphenous vein aorto-coronary graft atherosclerosis in patients with chronic kidney disease: more plaque calcification and necrosis, but less vasoconstrictor potential. Basic Res. Cardiol. 107, 303 (2012).","journal-title":"Basic Res. Cardiol."},{"key":"632_CR113","doi-asserted-by":"crossref","first-page":"H1222","DOI":"10.1152\/ajpheart.00358.2013","volume":"305","author":"P Kleinbongard","year":"2013","unstructured":"Kleinbongard, P. et al. Aspirate from human stented native coronary arteries vs. saphenous vein grafts: more endothelin but less particulate debris. Am. J. Physiol. Heart Circ. Physiol. 305, H1222\u2013H1229 (2013).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"632_CR114","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1161\/hc4501.099317","volume":"104","author":"E Grube","year":"2001","unstructured":"Grube, E. et al. Prevention of distal embolization during coronary angioplasty in saphenous vein grafts and native vessels using porous filter protection. Circulation 104, 2436\u20132441 (2001).","journal-title":"Circulation"},{"key":"632_CR115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/(SICI)1522-726X(199910)48:2<123::AID-CCD1>3.0.CO;2-O","volume":"48","author":"A Kini","year":"1999","unstructured":"Kini, A. et al. Incidence and mechanism of creatine kinase-MB enzyme elevation after coronary intervention with different devices. Catheter. Cardiovasc. Interv. 48, 123\u2013129 (1999).","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"632_CR116","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/0002-8703(94)90376-X","volume":"127","author":"MK Hong","year":"1994","unstructured":"Hong, M. K. et al. Clinical significance of distal embolization after transluminal extraction atherectomy in diffusely diseased saphenous vein grafts. Am. Heart J. 127, 1496\u20131503 (1994).","journal-title":"Am. Heart J."},{"key":"632_CR117","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1053\/euhj.2001.3035","volume":"23","author":"JPS Henriques","year":"2002","unstructured":"Henriques, J. P. S. et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur. Heart J. 23, 1112\u20131117 (2002).","journal-title":"Eur. Heart J."},{"key":"632_CR118","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00395-008-0745-9","volume":"103","author":"D Boese","year":"2008","unstructured":"Boese, D. et al. Impact of atherosclerotic plaque composition on coronary microembolization during percutaneous coronary interventions. Basic Res. Cardiol. 103, 587\u2013597 (2008).","journal-title":"Basic Res. Cardiol."},{"key":"632_CR119","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00059-013-3815-1","volume":"39","author":"HA Hildebrandt","year":"2013","unstructured":"Hildebrandt, H. A. et al. Fingerprints of periprocedural coronary microembolization on multimodality intravascular imaging. Herz 39, 115\u2013118 (2013).","journal-title":"Herz"},{"key":"632_CR120","doi-asserted-by":"crossref","first-page":"H2295","DOI":"10.1152\/ajpheart.01116.2006","volume":"292","author":"D Boese","year":"2007","unstructured":"Boese, D. et al. Release of TNF-a during stent implantation into saphenous vein aortocoronary bypass grafts and its relation to plaque extrusion and restenosis. Am. J. Physiol. Heart Circ. Physiol. 292, H2295\u2013H2299 (2007).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"632_CR121","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1161\/CIRCULATIONAHA.106.660779","volume":"115","author":"P Bahrmann","year":"2007","unstructured":"Bahrmann, P. et al. Detection of coronary microembolization by Doppler ultrasound in patients with stable angina pectoris undergoing elective percutaneous coronary interventions. Circulation 115, 600\u2013608 (2007).","journal-title":"Circulation"},{"key":"632_CR122","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00395-012-0289-x","volume":"107","author":"S Otto","year":"2012","unstructured":"Otto, S. et al. Microembolization and myonecrosis during elective percutaneous coronary interventions in diabetic patients: an intracoronary Doppler ultrasound study with 2-year clinical follow-up. Basic Res. Cardiol. 107, 289 (2012).","journal-title":"Basic Res. Cardiol."},{"key":"632_CR123","first-page":"H244","volume":"257","author":"M Hori","year":"1989","unstructured":"Hori, M. et al. Adenosine-induced hyperemia attenuates myocardial ischemia in coronary microembolization in dogs. Am. J. Physiol. 257, H244\u2013H251 (1989).","journal-title":"Am. J. Physiol."},{"key":"632_CR124","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0002-8703(92)90743-F","volume":"123","author":"S Nanto","year":"1992","unstructured":"Nanto, S. et al. Temporal increase in resting coronary blood flow causes an impairment of coronary flow reserve after coronary angioplasty. Am. Heart J. 123, 28\u201336 (1992).","journal-title":"Am. Heart J."},{"key":"632_CR125","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1161\/01.CIR.103.19.2339","volume":"103","author":"J Herrmann","year":"2001","unstructured":"Herrmann, J. et al. Abnormal coronary flow velocity reserve following coronary intervention is associated with cardiac marker elevation. Circulation 103, 2339\u20132345 (2001).","journal-title":"Circulation"},{"key":"632_CR126","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1161\/01.CIR.0000156328.28485.AD","volume":"111","author":"JB Selvanayagam","year":"2005","unstructured":"Selvanayagam, J. B. et al. Troponin elavation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury. Insights of cardiovascular magnetic resonance imaging. Circulation 111, 127\u20131032 (2005).","journal-title":"Circulation"},{"key":"632_CR127","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1161\/CIRCULATIONAHA.105.593210","volume":"114","author":"I Porto","year":"2006","unstructured":"Porto, I. et al. Plaque volume and occurence and location of periprocedural myocardial necrosis after percutaneous coronary intervention. Insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound. Circulation 114, 662\u2013669 (2006).","journal-title":"Circulation"},{"key":"632_CR128","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1161\/CIRCULATIONAHA.106.671909","volume":"116","author":"JB Selvanayagam","year":"2007","unstructured":"Selvanayagam, J. B. et al. Effect of distal embolization on myocardial perfusion reserve after percutaneous coronary intervention: a quantitative magnetic resonance perfusion study. Circulation 116, 1458\u20131464 (2007).","journal-title":"Circulation"},{"key":"632_CR129","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1136\/hrt.2009.173302","volume":"95","author":"K Rahimi","year":"2009","unstructured":"Rahimi, K. et al. Prognostic value of coronary revascularisation-related myocardial injury: a cardiac magnetic resonance imaging study. Heart 95, 1937\u20131943 (2009).","journal-title":"Heart"},{"key":"632_CR130","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/CIRCINTERVENTIONS.112.000184","volume":"6","author":"WR Davies","year":"2013","unstructured":"Davies, W. R. et al. Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: The CRISP stent trial long-term follow-up. Circ. Cardiovasc. Interv. 6, 246\u2013251 (2013).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"632_CR131","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.cjca.2012.11.022","volume":"29","author":"SJ Luo","year":"2013","unstructured":"Luo, S. J. et al. Remote ischemic preconditioning reduces myocardial injury in patients undergoing coronary stent implantation. Can. J. Cardiol. 29, 1084\u20131089 (2013).","journal-title":"Can. J. Cardiol."},{"key":"632_CR132","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ijcard.2014.03.026","volume":"173","author":"TA Zografos","year":"2014","unstructured":"Zografos, T. A., Katritsis, G. D. & Katritsis, D. G. Remote ischemic preconditioning reduces peri-procedural myocardial injury in elective percutaneous coronary intervention: a meta-analysis. Int. J. Cardiol. 173, 530\u2013532 (2014).","journal-title":"Int. J. Cardiol."},{"key":"632_CR133","volume":"9","author":"H Pei","year":"2014","unstructured":"Pei, H. et al. Remote ischemic preconditioning reduces perioperative cardiac and renal events in patients undergoing elective coronary intervention: a meta-analysis of 11 randomized trials. PLoS One 9, e115500 (2014).","journal-title":"PLoS One"},{"key":"632_CR134","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/ccd.24443","volume":"81","author":"A Prasad","year":"2013","unstructured":"Prasad, A. et al. Remote ischemic preconditioning immediately before percutaneous coronary intervention does not impact myocardial necrosis, inflammatory response, and circulating endothelial progenitor cell counts: a single center randomized sham controlled trial. Catheter. Cardiovasc. Interv. 81, 930\u2013936 (2013).","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"632_CR135","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCRESAHA.117.306878","volume":"117","author":"A Skyschally","year":"2015","unstructured":"Skyschally, A. et al. Across-species transfer of protection by remote ischemic preconditioning with species-specific myocardial signal transduction by reperfusion injury salvage kinase and survival activating factor enhancement pathways. Circ. Res. 117, 279\u2013288 (2015).","journal-title":"Circ. Res."},{"key":"632_CR136","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/CIRCRESAHA.118.313859","volume":"123","author":"HR Lieder","year":"2018","unstructured":"Lieder, H. R. et al. Vago-splenic axis in signal transduction of remote ischemic preconditioning in pigs and rats. Circ. Res. 123, 1152\u20131163 (2018).","journal-title":"Circ. Res."},{"key":"632_CR137","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jcin.2013.05.011","volume":"6","author":"G Crimi","year":"2013","unstructured":"Crimi, G. et al. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial. JACC Cardiovasc. Interv. 6, 1055\u20131063 (2013).","journal-title":"JACC Cardiovasc. Interv."},{"key":"632_CR138","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1093\/eurheartj\/ehv463","volume":"36","author":"I Eitel","year":"2015","unstructured":"Eitel, I. et al. Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: the randomized LIPSIA CONDITIONING trial. Eur. Heart J. 36, 3049\u20133057 (2015).","journal-title":"Eur. Heart J."},{"key":"632_CR139","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jcin.2014.05.015","volume":"8","author":"SK White","year":"2015","unstructured":"White, S. K. et al. Remote ischemic conditioning reduces myocardial infarct size and edema in patients with ST-segment elevation myocardial infarction. JACC Cardiovasc. Interv. 8, 178\u2013188 (2015).","journal-title":"JACC Cardiovasc. Interv."},{"key":"632_CR140","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1080\/AC.71.5.3167504","volume":"71","author":"Z Liu","year":"2016","unstructured":"Liu, Z., Zhao, L., Hong, D. & Gao, J. Remote ischaemic preconditioning reduces myocardial ischaemic reperfusion injury in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Acta Cardiol. 71, 596\u2013603 (2016).","journal-title":"Acta Cardiol."},{"key":"632_CR141","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jacc.2007.11.059","volume":"51","author":"T Cuisset","year":"2008","unstructured":"Cuisset, T. et al. Direct stenting for stable angina pectoris is associated with reduced periprocedural microcirculatory injury compared with stenting after pre-dilation. J. Am. Coll. Cardiol. 51, 1060\u20131065 (2008).","journal-title":"J. Am. Coll. Cardiol."},{"key":"632_CR142","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0735-1097(01)01701-6","volume":"39","author":"C Loubeyre","year":"2002","unstructured":"Loubeyre, C. et al. A randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction. J. Am. Coll. Cardiol. 39, 15\u201321 (2002).","journal-title":"J. Am. Coll. Cardiol."},{"key":"632_CR143","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijcard.2018.11.141","volume":"283","author":"M Saad","year":"2019","unstructured":"Saad, M. et al. Impact of direct stenting on myocardial injury assessed by cardiac magnetic resonance imaging and prognosis in ST-elevation myocardial infarction. Int. J. Cardiol. 283, 88\u201392 (2019).","journal-title":"Int. J. Cardiol."},{"key":"632_CR144","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ccd.10313","volume":"57","author":"JJ Popma","year":"2002","unstructured":"Popma, J. J. et al. Initial clinical experience with distal protection using the FilterWire in patients undergoing coronary artery and saphenous vein graft percutaneous intervention. Catheter. Cardiovasc. Interv. 57, 125\u2013134 (2002).","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"632_CR145","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/01.CIR.0000137821.94074.EE","volume":"110","author":"A Angelini","year":"2004","unstructured":"Angelini, A. et al. Distal protection with a filter device during coronary stenting in patients with stable and unstable angina. Circulation 110, 515\u2013521 (2004).","journal-title":"Circulation"},{"key":"632_CR146","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ahj.2005.01.016","volume":"150","author":"U Limbruno","year":"2005","unstructured":"Limbruno, U. et al. Distal embolization during primary angioplasty: histopathologic features and predictability. Am. Heart J. 150, 102\u2013108 (2005).","journal-title":"Am. Heart J."},{"key":"632_CR147","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/01.CIR.0000012783.63093.0C","volume":"105","author":"DS Baim","year":"2002","unstructured":"Baim, D. S. et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 105, 1285\u20131290 (2002).","journal-title":"Circulation"},{"key":"632_CR148","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1161\/01.CIR.0000080894.51311.0A","volume":"108","author":"GW Stone","year":"2003","unstructured":"Stone, G. W. et al. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation 108, 548\u2013553 (2003).","journal-title":"Circulation"},{"key":"632_CR149","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jcin.2008.03.009","volume":"1","author":"DJ Kereiakes","year":"2008","unstructured":"Kereiakes, D. J. et al. A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions. JACC Cardiovasc. Interv. 1, 248\u2013257 (2008).","journal-title":"JACC Cardiovasc. Interv."},{"key":"632_CR150","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.jacc.2007.06.039","volume":"50","author":"L Mauri","year":"2007","unstructured":"Mauri, L. et al. The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial. J. Am. Coll. Cardiol. 50, 1442\u20131449 (2007).","journal-title":"J. Am. Coll. Cardiol."},{"key":"632_CR151","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jcin.2015.01.032","volume":"8","author":"GW Stone","year":"2015","unstructured":"Stone, G. W. et al. Plaque characterization to inform the prediction and prevention of periprocedural myocardial infarction during percutaneous coronary intervention: the CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow). JACC Cardiovasc. Interv. 8, 927\u2013936 (2015).","journal-title":"JACC Cardiovasc. Interv."},{"key":"632_CR152","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jacc.2005.04.057","volume":"46","author":"F Burzotta","year":"2005","unstructured":"Burzotta, F. et al. Manual thrombus-aspiration improves myocardial reperfusion. The randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial. J. Am. Coll. Cardiol. 46, 371\u2013376 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"632_CR153","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/jama.293.9.1063","volume":"293","author":"GW Stone","year":"2005","unstructured":"Stone, G. W. et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA 293, 1063\u20131072 (2005).","journal-title":"JAMA"},{"key":"632_CR154","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.jacc.2006.03.068","volume":"48","author":"P Silva-Orrego","year":"2006","unstructured":"Silva-Orrego, P. et al. Thrombus aspiration before primary angioplasty improves myocardial reperfusion in acute myocardial infarction: the DEAR-MI (Dethrombosis to Enhance Acute Reperfusion in Myocardial Infarction) study. J. Am. Coll. Cardiol. 48, 1552\u20131559 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"632_CR155","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.amjcard.2006.08.038","volume":"99","author":"FA Cura","year":"2007","unstructured":"Cura, F. A. et al. Protection of distal embolization in high-risk patients with acute ST-segment elevation myocardial infarction (PREMIAR). Am. J. Cardiol. 99, 357\u2013363 (2007).","journal-title":"Am. J. Cardiol."},{"key":"632_CR156","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ccd.21190","volume":"70","author":"T Muramatsu","year":"2007","unstructured":"Muramatsu, T. et al. Comparison of myocardial perfusion by distal protection before and after primary stenting for acute myocardial infarction: angiographic and clinical results of a randomized controlled trial. Catheter. Cardiovasc. Interv. 70, 677\u2013682 (2007).","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"632_CR157","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jacc.2007.10.047","volume":"51","author":"H Kelbaek","year":"2008","unstructured":"Kelbaek, H. et al. Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial. J. Am. Coll. Cardiol. 51, 899\u2013905 (2008).","journal-title":"J. Am. Coll. Cardiol."},{"key":"632_CR158","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJMoa0706416","volume":"358","author":"T Svilaas","year":"2008","unstructured":"Svilaas, T. et al. Thrombus aspiration during primary percutaneous coronary intervention. N. Engl. J. Med. 358, 557\u2013567 (2008).","journal-title":"N. Engl. J. Med."},{"key":"632_CR159","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijcard.2007.03.124","volume":"123","author":"SJ Tahk","year":"2008","unstructured":"Tahk, S. J. et al. Distal protection device protects microvascular integrity during primary percutaneous intervention in acute myocardial infarction: a prospective, randomized, multicenter trial. Int. J. Cardiol. 123, 162\u2013168 (2008).","journal-title":"Int. J. Cardiol."},{"key":"632_CR160","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jcin.2009.07.013","volume":"2","author":"JDE Haeck","year":"2009","unstructured":"Haeck, J. D. E. et al. Randomized comparison of primary percutaneous coronary intervention with combined proximal embolic protection and thrombus aspiration versus primary percutaneous coronary intervention alone in ST-segment elevation myocardial infarction. The PREPARE (PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-Elevation) Study. JACC Cardiovasc. Interv. 2, 934\u2013943 (2009).","journal-title":"JACC Cardiovasc. Interv."},{"key":"632_CR161","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jacc.2008.10.017","volume":"53","author":"G Sardella","year":"2009","unstructured":"Sardella, G. et al. Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (thrombectomy with export catheter in infarct-related artery during primary percutaneous coronary intervention) prospective, randomized trial. J. Am. Coll. Cardiol. 53, 309\u2013315 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"632_CR162","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ahj.2010.07.024","volume":"160","author":"D Dudek","year":"2010","unstructured":"Dudek, D. et al. Thrombus aspiration followed by direct stenting: a novel strategy of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction. Results of the Polish-Italian-Hungarian randomized ThrombEctomy Trial (PIHRATE Trial). Am. Heart J. 160, 966\u2013972 (2010).","journal-title":"Am. Heart J."},{"key":"632_CR163","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jacc.2010.06.011","volume":"56","author":"A Migliorini","year":"2010","unstructured":"Migliorini, A. et al. Comparison of angioJet rheolytic thrombectomy before direct infarct artery stenting with direct stenting alone in patients with acute myocardial infarction. The JETSTENT trial. J. Am. Coll. Cardiol. 56, 1298\u20131306 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"632_CR164","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/ccd.22933","volume":"78","author":"M Ciszewski","year":"2011","unstructured":"Ciszewski, M. et al. Aspiration coronary thrombectomy for acute myocardial infarction increases myocardial salvage: single center randomized study. Catheter. Cardiovasc. Interv. 78, 523\u2013531 (2011).","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"632_CR165","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jcin.2012.08.013","volume":"5","author":"M De Carlo","year":"2012","unstructured":"De Carlo, M. et al. A prospective randomized trial of thrombectomy versus no thrombectomy in patients with ST-segment elevation myocardial infarction and thrombus-rich lesions: MUSTELA (multidevice thrombectomy in acute ST-segment elevation acute myocardial infarction) trial. JACC Cardiovasc. Interv. 5, 1223\u20131230 (2012).","journal-title":"JACC Cardiovasc. Interv."},{"key":"632_CR166","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1001\/jama.2012.421","volume":"307","author":"GW Stone","year":"2012","unstructured":"Stone, G. W. et al. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial. JAMA 307, 1817\u20131826 (2012).","journal-title":"JAMA"},{"key":"632_CR167","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1056\/NEJMoa1308789","volume":"369","author":"O Fr\u00f6bert","year":"2013","unstructured":"Fr\u00f6bert, O. et al. Thrombus aspiration during ST-segment elevation myocardial infarction. N. Engl. J. Med. 369, 1587\u20131597 (2013).","journal-title":"N. Engl. J. Med."},{"key":"632_CR168","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1056\/NEJMoa1415098","volume":"372","author":"SS Jolly","year":"2015","unstructured":"Jolly, S. S. et al. Randomized trial of primary PCI with or without routine manual thrombectomy. N. Engl. J. Med. 372, 1389\u20131398 (2015).","journal-title":"N. Engl. J. Med."},{"key":"632_CR169","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jcin.2015.09.010","volume":"9","author":"S Desch","year":"2016","unstructured":"Desch, S. et al. Thrombus aspiration in patients with ST-segment elevation myocardial infarction presenting late after symptom onset. JACC Cardiovasc. Interv. 9, 113\u2013122 (2016).","journal-title":"JACC Cardiovasc. Interv."},{"key":"632_CR170","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.jcin.2018.03.021","volume":"11","author":"K Hibi","year":"2018","unstructured":"Hibi, K. et al. A randomized study of distal filter protection versus conventional treatment during percutaneous coronary intervention in patients with attenuated plaque identified by intravascular ultrasound. JACC Cardiovasc. Interv. 11, 1545\u20131555 (2018).","journal-title":"JACC Cardiovasc. Interv."},{"key":"632_CR171","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00392-020-01613-0","volume":"109","author":"HJ Feistritzer","year":"2020","unstructured":"Feistritzer, H. J. et al. Long-term outcome after thrombus aspiration in non-ST-elevation myocardial infarction: results from the TATORT-NSTEMI trial: thrombus aspiration in acute myocardial infarction. Clin. Res. Cardiol. 109, 1223\u20131231 (2020).","journal-title":"Clin. Res. Cardiol."},{"key":"632_CR172","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.yjmcc.2011.06.022","volume":"52","author":"P Kleinbongard","year":"2012","unstructured":"Kleinbongard, P. et al. Lessons from human coronary aspirate. J. Mol. Cell. Cardiol. 52, 890\u2013896 (2012).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"632_CR173","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1182\/blood.V99.8.2794","volume":"99","author":"D Bonderman","year":"2002","unstructured":"Bonderman, D. et al. Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque. Blood 99, 2794\u20132800 (2002).","journal-title":"Blood"},{"key":"632_CR174","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1161\/01.CIR.0000124724.14491.6F","volume":"109","author":"C Rogers","year":"2004","unstructured":"Rogers, C. et al. Embolic protection with filtering or occlusion balloons during saphenous vein graft stenting retrieves identical volumes and sizes of particulate debris. Circulation 109, 1735\u20131740 (2004).","journal-title":"Circulation"},{"key":"632_CR175","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.amjcard.2005.02.006","volume":"95","author":"VH Quan","year":"2005","unstructured":"Quan, V. H. et al. Morphometric analysis of particulate debris extracted by four different embolic protection devices from coronary arteries, aortocoronary saphenous vein conduits, and carotid arteries. Am. J. Cardiol. 95, 1415\u20131419 (2005).","journal-title":"Am. J. Cardiol."},{"key":"632_CR176","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124904","volume":"10","author":"P Horn","year":"2015","unstructured":"Horn, P. et al. Release of intracoronary microparticles during stent implantation into stable atherosclerotic lesions under protection with an aspiration device. PLoS One 10, e0124904 (2015).","journal-title":"PLoS One"},{"key":"632_CR177","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1161\/CIRCRESAHA.116.304944","volume":"116","author":"A Mangold","year":"2015","unstructured":"Mangold, A. et al. Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size. Circ. Res. 116, 1182\u20131192 (2015).","journal-title":"Circ. Res."},{"key":"632_CR178","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvab217","author":"A Mangold","year":"2021","unstructured":"Mangold, A. et al. Culprit site extracellular DNA and microvascular obstruction in ST-elevation myocardial infarction. Cardiovasc. Res. https:\/\/doi.org\/10.1093\/cvr\/cvab217 (2021).","journal-title":"Cardiovasc. Res."},{"key":"632_CR179","first-page":"575","volume":"17","author":"J Salloum","year":"2005","unstructured":"Salloum, J., Tharpe, C., Vaughan, D. & Zhao, D. X. Release and elimination of soluble vasoactive factors during percutaneous coronary intervention of saphenous vein grafts: analysis using the PercuSurge GuardWire distal protection device. J. Invasive Cardiol. 17, 575\u2013579 (2005).","journal-title":"J. Invasive Cardiol."},{"key":"632_CR180","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1161\/CIRCRESAHA.110.235713","volume":"108","author":"P Kleinbongard","year":"2011","unstructured":"Kleinbongard, P. et al. Vasoconstrictor potential of coronary aspirate from patients undergoing stenting of saphenous vein aortocoronary bypass grafts and its pharmacological attenuation. Circ. Res. 108, 344\u2013352 (2011).","journal-title":"Circ. Res."},{"key":"632_CR181","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.CIR.0000158479.58589.0A","volume":"111","author":"W Maier","year":"2005","unstructured":"Maier, W. et al. Inflammatory markers at the site of ruptured plaque in acute myocardial infarction. Locally increased interleukin-6 and serum amyloid A but decreased c-reactive protein. Circulation 111, 1355\u20131361 (2005).","journal-title":"Circulation"},{"key":"632_CR182","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jacc.2005.10.053","volume":"47","author":"K Leineweber","year":"2006","unstructured":"Leineweber, K. et al. Intense vasoconstriction in response to aspirate from stented saphenous vein aortocoronary bypass grafts. J. Am. Coll. Cardiol. 47, 981\u2013986 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"632_CR183","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1093\/eurheartj\/ehaa703","volume":"41","author":"DM Leistner","year":"2020","unstructured":"Leistner, D. M. et al. Differential immunological signature at the culprit site distinguishes acute coronary syndrome with intact from acute coronary syndrome with ruptured fibrous cap: results from the prospective translational OPTICO-ACS study. Eur. Heart J. 41, 3549\u20133560 (2020).","journal-title":"Eur. Heart J."},{"key":"632_CR184","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1161\/01.CIR.0000037520.89770.5E","volume":"106","author":"J Herrmann","year":"2002","unstructured":"Herrmann, J. et al. Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction. Circulation 106, 2180\u20132183 (2002).","journal-title":"Circulation"},{"key":"632_CR185","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.amjcard.2004.07.140","volume":"94","author":"SR Mulukutla","year":"2004","unstructured":"Mulukutla, S. R. et al. Effect of statin therapy prior to elective percutaneous coronary intervention on frequency of periprocedural myocardial injury. Am. J. Cardiol. 94, 1363\u20131366 (2004).","journal-title":"Am. J. Cardiol."},{"key":"632_CR186","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/01.ATV.0000030360.72503.56","volume":"22","author":"GK Sukhova","year":"2002","unstructured":"Sukhova, G. K., Williams, K. & Libby, P. Statins reduce inflammation in atheroma of nonhuman primates independent of effects on serum cholesterol. Arterioscler. Thromb. Vasc. Biol. 22, 1452\u20131458 (2002).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"632_CR187","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.ehj.2004.07.017","volume":"25","author":"C Briguori","year":"2004","unstructured":"Briguori, C. et al. Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction. Eur. Heart J. 25, 1822\u20131828 (2004).","journal-title":"Eur. Heart J."},{"key":"632_CR188","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/01.CIR.0000137828.06205.87","volume":"110","author":"V Pasceri","year":"2004","unstructured":"Pasceri, V. et al. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention. Results from the ARMYDA (atorvastatin for reduction of myocardial damage during angioplasty) study. Circulation 110, 674\u2013678 (2004).","journal-title":"Circulation"},{"key":"632_CR189","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.jacc.2006.06.061","volume":"48","author":"G Patti","year":"2006","unstructured":"Patti, G. et al. Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (atorvastatin for reduction of myocardial damage during angioplasty-cell adhesion molecules) substudy. J. Am. Coll. Cardiol. 48, 1560\u20131566 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"632_CR190","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jacc.2007.02.025","volume":"49","author":"G Patti","year":"2007","unstructured":"Patti, G. et al. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial. J. Am. Coll. Cardiol. 49, 1272\u20131278 (2007).","journal-title":"J. Am. Coll. Cardiol."},{"key":"632_CR191","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jacc.2009.05.028","volume":"54","author":"G Di Sciascio","year":"2009","unstructured":"Di Sciascio, G. et al. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention. Results of the ARMYDA-RECAPTURE (atorvastatin for reduction of myocardial damage during angioplasty) randomized trial. J. Am. Coll. Cardiol. 54, 558\u2013565 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"632_CR192","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1161\/CIRCULATIONAHA.110.002451","volume":"123","author":"G Patti","year":"2011","unstructured":"Patti, G. et al. Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies. Circulation 123, 1622\u20131632 (2011).","journal-title":"Circulation"},{"key":"632_CR193","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0735-1097(02)02816-4","volume":"41","author":"RM Bell","year":"2003","unstructured":"Bell, R. M. & Yellon, D. M. Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway. J. Am. Coll. Cardiol. 41, 508\u2013515 (2003).","journal-title":"J. Am. Coll. Cardiol."},{"key":"632_CR194","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/01.fjc.0000154376.82445.06","volume":"45","author":"CA Efthymiou","year":"2005","unstructured":"Efthymiou, C. A., Mocanu, M. M. & Yellon, D. M. Atorvastatin and myocardial reperfusion injury. New pleiotropic effect implicating multiple prosurvival signaling. J. Cardiovasc. Pharmacol. 45, 247\u2013252 (2005).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"632_CR195","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jacc.2019.05.020","volume":"74","author":"G Mendieta","year":"2019","unstructured":"Mendieta, G. et al. Intravenous statin administration during ischemia exerts cardioprotective effects. J. Am. Coll. Cardiol. 74, 475\u2013477 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"632_CR196","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"M Valgimigli","year":"2018","unstructured":"Valgimigli, M. et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 39, 213\u2013260 (2018).","journal-title":"Eur. Heart J."},{"key":"632_CR197","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/jama.2021.0716","volume":"325","author":"H Kamran","year":"2021","unstructured":"Kamran, H. et al. Oral antiplatelet therapy after acute coronary syndrome: a review. JAMA 325, 1545\u20131555 (2021).","journal-title":"JAMA"},{"key":"632_CR198","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1161\/01.CIR.0000161383.06692.D4","volume":"111","author":"G Patti","year":"2005","unstructured":"Patti, G. et al. Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention. Results from the ARMYDA-2 (antiplatelet therapy for reduction of myocardial damage during angioplasty) study. Circulation 111, 2099\u20132106 (2005).","journal-title":"Circulation"},{"key":"632_CR199","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/1074248412467692","volume":"18","author":"XM Yang","year":"2013","unstructured":"Yang, X. M. et al. Platelet P2Y(1)(2) blockers confer direct postconditioning-like protection in reperfused rabbit hearts. J. Cardiovasc. Pharmacol. Ther. 18, 251\u2013262 (2013).","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"632_CR200","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/1074248419882923","volume":"25","author":"MV Cohen","year":"2020","unstructured":"Cohen, M. V. & Downey, J. M. What are optimal P2Y12 inhibitor and schedule of administration in patients with acute coronary syndrome? J. Cardiovasc. Pharmacol. Ther. 25, 121\u2013130 (2020).","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"632_CR201","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00395-020-00830-y","volume":"115","author":"Z He","year":"2020","unstructured":"He, Z., Davidson, S. M. & Yellon, D. M. The importance of clinically relevant background therapy in cardioprotective studies. Basic Res. Cardiol. 115, 69 (2020).","journal-title":"Basic Res. Cardiol."},{"key":"632_CR202","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJMoa1908973","volume":"381","author":"S Schuepke","year":"2019","unstructured":"Schuepke, S. et al. Ticagrelor or prasugrel in patients with acute coronary syndromes. N. Engl. J. Med. 381, 1524\u20131534 (2019).","journal-title":"N. Engl. J. Med."},{"key":"632_CR203","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.cjca.2019.05.003","volume":"35","author":"A Karathanos","year":"2019","unstructured":"Karathanos, A. et al. Routine glycoprotein IIb\/IIIa Iinhibitor therapy in ST-segment elevation myocardial infarction: a meta-analysis. Can. J. Cardiol. 35, 1576\u20131588 (2019).","journal-title":"Can. J. Cardiol."},{"key":"632_CR204","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.2018.19802","volume":"321","author":"PJ McCartney","year":"2019","unstructured":"McCartney, P. J. et al. Effect of low-dose intracoronary alteplase during primary percutaneous coronary intervention on microvascular obstruction in patients with acute myocardial infarction: a randomized clinical trial. JAMA 321, 56\u201368 (2019).","journal-title":"JAMA"},{"key":"632_CR205","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jcin.2013.02.009","volume":"6","author":"G Niccoli","year":"2013","unstructured":"Niccoli, G. et al. Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study. JACC Cardiovasc. Interv. 6, 580\u2013589 (2013).","journal-title":"JACC Cardiovasc. Interv."},{"key":"632_CR206","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/eurheartj\/ehw136","volume":"37","author":"SA Nazir","year":"2016","unstructured":"Nazir, S. A. et al. Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial. Eur. Heart J. 37, 1910\u20131919 (2016).","journal-title":"Eur. Heart J."},{"key":"632_CR207","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijcard.2015.09.005","volume":"202","author":"H Bulluck","year":"2016","unstructured":"Bulluck, H., Sirker, A., Loke, Y. K., Garcia-Dorado, D. & Hausenloy, D. J. Clinical benefit of adenosine as an adjunct to reperfusion in ST-elevation myocardial infarction patients: an updated meta-analysis of randomized controlled trials. Int. J. Cardiol. 202, 228\u2013237 (2016).","journal-title":"Int. J. Cardiol."},{"key":"632_CR208","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/(SICI)1097-0304(199610)39:2<113::AID-CCD1>3.0.CO;2-I","volume":"39","author":"BM Kaplan","year":"1996","unstructured":"Kaplan, B. M. et al. Treatment of no-reflow in degenerated saphenous vein graft interventions: comparison of intracoronary verapamil and nitroglycerin. Cathet. Cardiovasc. Diagn. 39, 113\u2013118 (1996).","journal-title":"Cathet. Cardiovasc. Diagn."},{"key":"632_CR209","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119\u20131131 (2017).","journal-title":"N. Engl. J. Med."},{"key":"632_CR210","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.3390\/jcm8122072","volume":"8","author":"L Liberale","year":"2019","unstructured":"Liberale, L. et al. Interleukin-1beta mediates arterial thrombus formation via NET-associated tissue factor. J. Clin. Med. 8, 2072 (2019).","journal-title":"J. Clin. Med."},{"key":"632_CR211","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1093\/eurheartj\/ehy310","volume":"39","author":"PM Ridker","year":"2018","unstructured":"Ridker, P. M. et al. Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS). Eur. Heart J. 39, 3499\u20133507 (2018).","journal-title":"Eur. Heart J."},{"key":"632_CR212","volume":"13","author":"D Cao","year":"2020","unstructured":"Cao, D., Chiarito, M. & Mehran, R. Treating inflammation prior to percutaneous coronary intervention: does the heart care? Circ. Cardiovasc. Interv. 13, e009127 (2020).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"632_CR213","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/eurheartj\/ehu272","volume":"36","author":"AC Morton","year":"2015","unstructured":"Morton, A. C. et al. The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA heart study. Eur. Heart J. 36, 377\u2013384 (2015).","journal-title":"Eur. Heart J."},{"key":"632_CR214","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1093\/eurheartj\/ehw171","volume":"37","author":"O Kleveland","year":"2016","unstructured":"Kleveland, O. et al. Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial. Eur. Heart J. 37, 2406\u20132413 (2016).","journal-title":"Eur. Heart J."},{"key":"632_CR215","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1161\/CIRCULATIONAHA.120.053318","volume":"143","author":"MAS Meyer","year":"2021","unstructured":"Meyer, M. A. S. et al. Treatment effects of interleukin-6 receptor antibodies for modulating the systemic inflammatory response after out-of-hospital cardiac arrest (The IMICA Trial): a double-blinded, placebo-controlled, single-center, randomized, clinical trial. Circulation 143, 1841\u20131851 (2021).","journal-title":"Circulation"},{"key":"632_CR216","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jacc.2021.02.049","volume":"77","author":"K Broch","year":"2021","unstructured":"Broch, K. et al. Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction. J. Am. Coll. Cardiol. 77, 1845\u20131855 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"key":"632_CR217","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/j.jacc.2013.03.003","volume":"61","author":"JC Tardif","year":"2013","unstructured":"Tardif, J. C. et al. Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial. J. Am. Coll. Cardiol. 61, 2048\u20132055 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"632_CR218","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/CIRCULATIONAHA.115.017611","volume":"132","author":"S Deftereos","year":"2015","unstructured":"Deftereos, S. et al. Anti-inflammatory treatment with colchicine in acute myocardial infarction: a pilot study. Circulation 132, 1395\u20131403 (2015).","journal-title":"Circulation"},{"key":"632_CR219","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002128","volume":"4","author":"GJ Martinez","year":"2015","unstructured":"Martinez, G. J. et al. Colchicine acutely suppresses local cardiac production of inflammatory cytokines in patients with an acute coronary syndrome. J. Am. Heart Assoc. 4, e002128 (2015).","journal-title":"J. Am. Heart Assoc."},{"key":"632_CR220","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.acvd.2016.10.004","volume":"110","author":"M Akodad","year":"2017","unstructured":"Akodad, M. et al. COLIN trial: value of colchicine in the treatment of patients with acute myocardial infarction and inflammatory response. Arch. Cardiovasc. Dis. 110, 395\u2013402 (2017).","journal-title":"Arch. Cardiovasc. Dis."},{"key":"632_CR221","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ahj.2019.06.003","volume":"215","author":"T Hennessy","year":"2019","unstructured":"Hennessy, T. et al. The low dose colchicine after myocardial infarction (LoDoCo-MI) study: a pilot randomized placebo controlled trial of colchicine following acute myocardial infarction. Am. Heart J. 215, 62\u201369 (2019).","journal-title":"Am. Heart J."},{"key":"632_CR222","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008717","volume":"13","author":"B Shah","year":"2020","unstructured":"Shah, B. et al. Effects of ccute colchicine administration prior to percutaneous coronary intervention: COLCHICINE-PCI randomized trial. Circ. Cardiovasc. Interv. 13, e008717 (2020).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"632_CR223","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.009992","volume":"14","author":"J Cole","year":"2021","unstructured":"Cole, J. et al. Colchicine to prevent periprocedural myocardial injury in percutaneous coronary intervention: the COPE-PCI pilot trial. Circ. Cardiovasc. Interv. 14, e009992 (2021).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"632_CR224","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga, Z. et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 395, 1417\u20131418 (2020).","journal-title":"Lancet"},{"key":"632_CR225","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41569-020-00469-1","volume":"18","author":"SX Gu","year":"2021","unstructured":"Gu, S. X. et al. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nat. Rev. Cardiol. 18, 194\u2013209 (2021).","journal-title":"Nat. Rev. Cardiol."},{"key":"632_CR226","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jacbts.2020.12.009","volume":"6","author":"P Canzano","year":"2021","unstructured":"Canzano, P. et al. Platelet and endothelial activation as potential mechanisms behind the thrombotic complications of COVID-19 patients. JACC Basic Transl. Sci. 6, 202\u2013218 (2021).","journal-title":"JACC Basic Transl. Sci."},{"key":"632_CR227","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00395-021-00882-8","volume":"116","author":"JUG Wagner","year":"2021","unstructured":"Wagner, J. U. G. et al. Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants. Basic Res. Cardiol. 116, 42 (2021).","journal-title":"Basic Res. Cardiol."},{"key":"632_CR228","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1093\/eurheartj\/ehaa664","volume":"41","author":"C Basso","year":"2020","unstructured":"Basso, C. et al. Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study. Eur. Heart J. 41, 3827\u20133835 (2020).","journal-title":"Eur. Heart J."},{"key":"632_CR229","doi-asserted-by":"crossref","first-page":"107300","DOI":"10.1016\/j.carpath.2020.107300","volume":"50","author":"MK Halushka","year":"2021","unstructured":"Halushka, M. K. & Vander Heide, R. S. Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations. Cardiovasc. Pathol. 50, 107300 (2021).","journal-title":"Cardiovasc. Pathol."},{"key":"632_CR230","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/CIRCULATIONAHA.120.051828","volume":"143","author":"D Pellegrini","year":"2021","unstructured":"Pellegrini, D. et al. Microthrombi as a major cause of cardiac injury in COVID-19: a pathologic study. Circulation 143, 1031\u20131042 (2021).","journal-title":"Circulation"},{"key":"632_CR231","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jamacardio.2020.7308","volume":"6","author":"A Blasco","year":"2021","unstructured":"Blasco, A. et al. Assessment of neutrophil extracellular traps in coronary thrombus of a case series of patients with COVID-19 and myocardial infarction. JAMA Cardiol. 6, 469\u2013474 (2021).","journal-title":"JAMA Cardiol."},{"key":"632_CR232","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","volume":"18","author":"K Stark","year":"2021","unstructured":"Stark, K. & Massberg, S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat. Rev. Cardiol. 18, 666\u2013682 (2021).","journal-title":"Nat. Rev. Cardiol."},{"key":"632_CR233","first-page":"A2200","volume":"99","author":"G Heusch","year":"2002","unstructured":"Heusch, G. & Erbel, R. Koronare mikroembolisation. Dtsch. \u00c4rztebl. 99, A2200\u2013A2202 (2002).","journal-title":"Dtsch. \u00c4rztebl."},{"key":"632_CR234","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.4244\/EIJ-D-15-00207","volume":"12","author":"HA Hildebrandt","year":"2016","unstructured":"Hildebrandt, H. A. et al. Quantification and characterization of released plaque material during bioresorbable vascular scaffold implantation into right coronary artery lesions by multimodality intracoronary imaging. EuroIntervention 12, 1481\u20131489 (2016).","journal-title":"EuroIntervention"},{"key":"632_CR235","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF03044228","volume":"24","author":"R Erbel","year":"1999","unstructured":"Erbel, R. & Heusch, G. Coronary microembolization - its role in acute coronary syndromes and interventions. Herz 24, 558\u2013575 (1999).","journal-title":"Herz"}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41569-021-00632-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-021-00632-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-021-00632-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T23:16:59Z","timestamp":1733959019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41569-021-00632-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,16]]},"references-count":235,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["632"],"URL":"https:\/\/doi.org\/10.1038\/s41569-021-00632-2","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,16]]},"assertion":[{"value":"4 October 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}